PATRIARCA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.663
NA - Nord America 1.589
AS - Asia 1.257
SA - Sud America 150
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 43
OC - Oceania 9
Totale 4.791
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 485
RU - Federazione Russa 476
IT - Italia 369
IE - Irlanda 260
CN - Cina 203
VN - Vietnam 169
HK - Hong Kong 148
DE - Germania 145
SE - Svezia 121
BR - Brasile 107
FR - Francia 76
BD - Bangladesh 69
IN - India 54
FI - Finlandia 50
GB - Regno Unito 43
CA - Canada 39
UA - Ucraina 30
KR - Corea 24
MX - Messico 20
ID - Indonesia 19
TR - Turchia 18
BJ - Benin 17
PL - Polonia 16
AR - Argentina 14
NL - Olanda 14
ES - Italia 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
LT - Lituania 11
AU - Australia 9
IR - Iran 9
PK - Pakistan 9
JP - Giappone 8
AT - Austria 7
SA - Arabia Saudita 7
CL - Cile 6
CO - Colombia 6
EC - Ecuador 6
IQ - Iraq 5
JM - Giamaica 4
JO - Giordania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 4.711
Città #
Dublin 253
San Jose 219
Hong Kong 148
Singapore 138
Ashburn 131
Council Bluffs 112
Piemonte 70
Los Angeles 68
Chandler 66
Beijing 59
Columbus 59
Novara 57
Ho Chi Minh City 43
Moscow 42
Munich 42
New York 41
Helsinki 40
Lauterbourg 39
Hanoi 36
Jacksonville 34
Orem 29
Lawrence 25
Princeton 25
Santa Clara 25
Boardman 24
Buffalo 22
Bremen 21
Seoul 21
São Paulo 19
Chennai 18
Frankfurt am Main 18
Toronto 18
Cotonou 17
Milan 17
San Mateo 16
Phoenix 15
Falkenstein 14
Turin 14
Wilmington 14
Brooklyn 13
Genoa 13
Grafing 13
Haiphong 13
London 13
Atlanta 12
Dallas 12
Houston 12
Montreal 12
Rome 12
Guangzhou 11
Jakarta 11
Warsaw 11
Mexico City 10
Nuremberg 10
St Louis 10
Strasbourg 10
Turku 10
Brno 9
Chicago 9
Poplar 9
Dong Ket 8
Redondo Beach 8
San Bernardino 8
Stockholm 8
Sydney 8
Amsterdam 7
Andover 7
Boston 7
Da Nang 7
Johannesburg 7
Assago 6
Bologna 6
Naples 6
Shanghai 6
Tokyo 6
Ankara 5
Bexley 5
Denver 5
Milwaukee 5
Mumbai 5
New Delhi 5
Vercelli 5
Charlotte 4
Dalian 4
Hefei 4
Islamabad 4
Istanbul 4
Quito 4
Riyadh 4
San Francisco 4
Santiago 4
Tianjin 4
Vienna 4
West Jordan 4
Addis Ababa 3
Amman 3
Baku 3
Barnet 3
Belgrade 3
Belo Horizonte 3
Totale 2.510
Nome #
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 241
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 238
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 180
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 146
Targeting p53 in chronic lymphocytic leukemia 143
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 138
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 138
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 133
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 133
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 127
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 127
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 127
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 123
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 122
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 120
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 118
Precision medicine management of chronic lymphocytic leukemia 116
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 115
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 114
Atypical chronic myeloid leukemia: Where are we now? 114
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 110
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 109
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 107
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab 106
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 105
A step ahead toward precision medicine for chronic lymphocytic leukemia 105
Precision Medicine in Systemic Mastocytosis 105
A phase 3 study of pelebresib plus ruxolitinib for JAK inhibitor-naive patients with myelofibrosis 103
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 103
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies 102
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 99
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 98
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 93
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia 92
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 90
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 86
Prescription patterns of venetoclax in acute myeloid leukemia 84
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report 61
Intravascular lymphoma: from vessels to genes 57
Investigational drugs for the treatment of diffuse large B-cell lymphoma 57
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study 43
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a ZRSR2 Mutation 38
Liquid biopsy in lymphomas: a potential tool for refining diagnosis and disease monitoring 15
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics 10
Totale 4.791
Categoria #
all - tutte 23.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 0 4 21 34 18 10 23 13 13 36 50 45
2022/2023543 46 22 47 4 35 47 25 20 250 3 25 19
2023/2024269 27 23 23 7 38 9 36 6 4 5 37 54
2024/2025824 21 19 43 10 28 30 47 138 124 51 113 200
2025/20262.451 116 76 121 273 263 164 371 409 187 214 131 126
2026/2027269 104 165 0 0 0 0 0 0 0 0 0 0
Totale 4.791